Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2005

Open Access 01-09-2005 | Research article

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Authors: Vineeth S Rajkumar, Kevin Howell, Katalin Csiszar, Christopher P Denton, Carol M Black, David J Abraham

Published in: Arthritis Research & Therapy | Issue 5/2005

Login to get access

Abstract

The mechanisms by which microvascular damage leads to dermal fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) are unclear. We hypothesized that microvascular pericytes constitute a cellular link between microvascular damage and fibrosis by transdifferentiating into myofibroblasts. We used a combination of immunohistochemistry and double immunofluorescence labelling of frozen skin biopsies taken from normal and dcSSc patients to determine whether a phenotypic link between pericytes and myofibroblasts exists in dcSSc. Using α-smooth muscle actin, the ED-A splice variant of fibronectin (ED-A FN) and Thy-1 to identify myofibroblasts, we demonstrated the presence of myofibroblasts in fibrotic dcSSc skin. Myofibroblasts were totally absent from control skin, atrophic stage dcSSc skin and non-lesional skin. Using double immunofluorescence labelling, both myofibroblasts and pericytes were shown to express ED-A FN and Thy-1 in dcSSc skin but not in control skin. Proliferating cell nuclear antigen was also expressed by myofibroblasts and pericytes in dcSSc skin while being absent in control skin. These observations suggest that the presence of myofibroblasts may represent a transitional phase during the fibrotic stages of dcSSc and that Thy-1+ve pericytes participate in the fibrogenic development of dcSSc by synthesizing ED-A FN, which may be associated with a proliferation and transition of pericytes and fibroblasts to myofibroblasts, thus linking microvascular damage and fibrosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Black CM: The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses. The Parkes Weber Lecture 1994. J R Coll Physicians Lond. 1995, 29: 119-130.PubMed Black CM: The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses. The Parkes Weber Lecture 1994. J R Coll Physicians Lond. 1995, 29: 119-130.PubMed
2.
go back to reference Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol. 1992, 166: 255-263. 10.1002/path.1711660307.CrossRefPubMed Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol. 1992, 166: 255-263. 10.1002/path.1711660307.CrossRefPubMed
3.
go back to reference Sims DE: Diversity within pericytes. Clin Exp Pharmacol Physiol. 2000, 27: 842-846. 10.1046/j.1440-1681.2000.03343.x.CrossRefPubMed Sims DE: Diversity within pericytes. Clin Exp Pharmacol Physiol. 2000, 27: 842-846. 10.1046/j.1440-1681.2000.03343.x.CrossRefPubMed
4.
go back to reference Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM: Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum. 1999, 42: 930-941. 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1.CrossRefPubMed Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM: Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum. 1999, 42: 930-941. 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1.CrossRefPubMed
5.
go back to reference Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003, 200: 500-503. 10.1002/path.1427.CrossRefPubMed Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003, 200: 500-503. 10.1002/path.1427.CrossRefPubMed
6.
go back to reference Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002, 3: 349-363. 10.1038/nrm809.CrossRefPubMed Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002, 3: 349-363. 10.1038/nrm809.CrossRefPubMed
7.
go back to reference Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995, 146: 56-66.PubMedCentralPubMed Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995, 146: 56-66.PubMedCentralPubMed
8.
go back to reference Zhang HY, Phan SH: Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol. 1999, 21: 658-665.CrossRefPubMed Zhang HY, Phan SH: Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol. 1999, 21: 658-665.CrossRefPubMed
9.
go back to reference Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G: Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol. 2001, 159: 1009-1020.PubMedCentralCrossRefPubMed Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G: Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol. 2001, 159: 1009-1020.PubMedCentralCrossRefPubMed
10.
go back to reference Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G: The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol. 1998, 142: 873-881. 10.1083/jcb.142.3.873.PubMedCentralCrossRefPubMed Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G: The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol. 1998, 142: 873-881. 10.1083/jcb.142.3.873.PubMedCentralCrossRefPubMed
11.
go back to reference Odenthal M, Neubauer K, Meyer zum Buschenfelde KH, Ramadori G: Localization and mRNA steady-state level of cellular fibronectin in rat liver undergoing a CCl4-induced acute damage or fibrosis. Biochim Biophys Acta. 1993, 1181: 266-272.CrossRefPubMed Odenthal M, Neubauer K, Meyer zum Buschenfelde KH, Ramadori G: Localization and mRNA steady-state level of cellular fibronectin in rat liver undergoing a CCl4-induced acute damage or fibrosis. Biochim Biophys Acta. 1993, 1181: 266-272.CrossRefPubMed
12.
go back to reference Pujuguet P, Hammann A, Moutet M, Samuel JL, Martin F, Martin M: Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol. 1996, 148: 579-592.PubMedCentralPubMed Pujuguet P, Hammann A, Moutet M, Samuel JL, Martin F, Martin M: Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol. 1996, 148: 579-592.PubMedCentralPubMed
13.
go back to reference Sappino AP, Masouye I, Saurat JH, Gabbiani G: Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol. 1990, 137: 585-591.PubMedCentralPubMed Sappino AP, Masouye I, Saurat JH, Gabbiani G: Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol. 1990, 137: 585-591.PubMedCentralPubMed
14.
go back to reference Jelaska A, Korn JH: Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 2000, 43: 2230-2239. 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8.CrossRefPubMed Jelaska A, Korn JH: Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 2000, 43: 2230-2239. 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8.CrossRefPubMed
15.
go back to reference Borrello MA, Phipps RP: Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol. 1996, 173: 198-206. 10.1006/cimm.1996.0268.CrossRefPubMed Borrello MA, Phipps RP: Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol. 1996, 173: 198-206. 10.1006/cimm.1996.0268.CrossRefPubMed
16.
go back to reference Silvera MR, Sempowski GD, Phipps RP: Expression of TGF-beta isoforms by Thy-1+ and Thy-1- pulmonary fibroblast subsets: evidence for TGF-beta as a regulator of IL-1-dependent stimulation of IL-6. Lymphokine Cytokine Res. 1994, 13: 277-285.PubMed Silvera MR, Sempowski GD, Phipps RP: Expression of TGF-beta isoforms by Thy-1+ and Thy-1- pulmonary fibroblast subsets: evidence for TGF-beta as a regulator of IL-1-dependent stimulation of IL-6. Lymphokine Cytokine Res. 1994, 13: 277-285.PubMed
17.
go back to reference Derdak S, Penney DP, Keng P, Felch ME, Brown D, Phipps RP: Differential collagen and fibronectin production by Thy 1+ and Thy 1- lung fibroblast subpopulations. Am J Physiol. 1992, 263: L283-L290.PubMed Derdak S, Penney DP, Keng P, Felch ME, Brown D, Phipps RP: Differential collagen and fibronectin production by Thy 1+ and Thy 1- lung fibroblast subpopulations. Am J Physiol. 1992, 263: L283-L290.PubMed
18.
go back to reference Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP: Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol. 2003, 163: 1291-1300.PubMedCentralCrossRefPubMed Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP: Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol. 2003, 163: 1291-1300.PubMedCentralCrossRefPubMed
19.
go back to reference Schmitt-Graff A, Kruger S, Bochard F, Gabbiani G, Denk H: Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol. 1991, 138: 1233-1242.PubMedCentralPubMed Schmitt-Graff A, Kruger S, Bochard F, Gabbiani G, Denk H: Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol. 1991, 138: 1233-1242.PubMedCentralPubMed
20.
go back to reference Hattori M, Horita S, Yoshioka T, Yamaguchi Y, Kawaguchi H, Ito K: Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am J Kidney Dis. 1997, 30: 632-638.CrossRefPubMed Hattori M, Horita S, Yoshioka T, Yamaguchi Y, Kawaguchi H, Ito K: Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am J Kidney Dis. 1997, 30: 632-638.CrossRefPubMed
21.
go back to reference Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE: Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res. 1998, 13: 828-838.CrossRefPubMed Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE: Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res. 1998, 13: 828-838.CrossRefPubMed
22.
go back to reference Ivarsson M, Sundberg C, Farrokhnia N, Pertoft H, Rubin K, Gerdin B: Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Res. 1996, 229: 336-349. 10.1006/excr.1996.0379.CrossRefPubMed Ivarsson M, Sundberg C, Farrokhnia N, Pertoft H, Rubin K, Gerdin B: Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Res. 1996, 229: 336-349. 10.1006/excr.1996.0379.CrossRefPubMed
23.
go back to reference Sundberg C, Ivarsson M, Gerdin B, Rubin K: Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest. 1996, 74: 452-466.PubMed Sundberg C, Ivarsson M, Gerdin B, Rubin K: Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest. 1996, 74: 452-466.PubMed
24.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15: 202-205.PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15: 202-205.PubMed
25.
go back to reference Bombardieri S, Medsger TA, Silman AJ, Valentini G: The assessment of the patient with systemic sclerosis. Introduction. Clin Exp Rheumatol. 2003, 21 (3 Suppl 29): S2-S4.PubMed Bombardieri S, Medsger TA, Silman AJ, Valentini G: The assessment of the patient with systemic sclerosis. Introduction. Clin Exp Rheumatol. 2003, 21 (3 Suppl 29): S2-S4.PubMed
26.
go back to reference Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, Ravazzola M, Orci L: Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem. 1989, 37: 315-321.CrossRefPubMed Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, Ravazzola M, Orci L: Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem. 1989, 37: 315-321.CrossRefPubMed
27.
go back to reference Saalbach A, Kraft R, Herrmann K, Haustein UF, Anderegg U: The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res. 1998, 290: 360-366. 10.1007/s004030050318.CrossRefPubMed Saalbach A, Kraft R, Herrmann K, Haustein UF, Anderegg U: The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res. 1998, 290: 360-366. 10.1007/s004030050318.CrossRefPubMed
28.
go back to reference Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ: Monoclonal antibody PAL-E specific for endothelium. Lab Invest. 1985, 52: 71-76.PubMed Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ: Monoclonal antibody PAL-E specific for endothelium. Lab Invest. 1985, 52: 71-76.PubMed
29.
go back to reference Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ, de Waal RM: Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 2002, 62: 7059-7065.PubMed Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ, de Waal RM: Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 2002, 62: 7059-7065.PubMed
30.
go back to reference Peters JH, Hynes RO: Fibronectin isoform distribution in the mouse. I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread codistribution in the developing mouse embryo. Cell Adhes Commun. 1996, 4: 103-125.CrossRefPubMed Peters JH, Hynes RO: Fibronectin isoform distribution in the mouse. I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread codistribution in the developing mouse embryo. Cell Adhes Commun. 1996, 4: 103-125.CrossRefPubMed
31.
go back to reference Li PA, He Q, Cao T, Yong G, Szauter KM, Fong KS, Karlsson J, Keep MF, Csiszar K.: Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res Mol Brain Res. 2004, 120: 115-122. 10.1016/j.molbrainres.2003.10.013.CrossRefPubMed Li PA, He Q, Cao T, Yong G, Szauter KM, Fong KS, Karlsson J, Keep MF, Csiszar K.: Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res Mol Brain Res. 2004, 120: 115-122. 10.1016/j.molbrainres.2003.10.013.CrossRefPubMed
32.
go back to reference Smith-Mungo LI, Kagan HM: Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998, 16: 387-398. 10.1016/S0945-053X(98)90012-9.CrossRefPubMed Smith-Mungo LI, Kagan HM: Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998, 16: 387-398. 10.1016/S0945-053X(98)90012-9.CrossRefPubMed
33.
go back to reference Chvapil M, McCarthy DW, Misiorowski RL, Madden JW, Peacock EE: Activity and extractability of lysyl oxidase and collagen proteins in developing granuloma tissue. Proc Soc Exp Biol Med. 1974, 146: 688-693.CrossRefPubMed Chvapil M, McCarthy DW, Misiorowski RL, Madden JW, Peacock EE: Activity and extractability of lysyl oxidase and collagen proteins in developing granuloma tissue. Proc Soc Exp Biol Med. 1974, 146: 688-693.CrossRefPubMed
34.
go back to reference Kelman Z: PCNA: structure, functions and interactions. Oncogene. 1997, 14: 629-640. 10.1038/sj.onc.1200886.CrossRefPubMed Kelman Z: PCNA: structure, functions and interactions. Oncogene. 1997, 14: 629-640. 10.1038/sj.onc.1200886.CrossRefPubMed
35.
go back to reference Cutolo M, Sulli A, Pizzorni C, Accardo S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000, 27: 155-160.PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000, 27: 155-160.PubMed
36.
go back to reference Kobayashi H, Ishii M, Chanoki M, Yashiro N, Fushida H, Fukai K, Kono T, Hamada T, Wakasaki H, Ooshima A: Immunohistochemical localization of lysyl oxidase in normal human skin. Br J Dermatol. 1994, 131: 325-330.CrossRefPubMed Kobayashi H, Ishii M, Chanoki M, Yashiro N, Fushida H, Fukai K, Kono T, Hamada T, Wakasaki H, Ooshima A: Immunohistochemical localization of lysyl oxidase in normal human skin. Br J Dermatol. 1994, 131: 325-330.CrossRefPubMed
37.
go back to reference Hein S, Yamamoto SY, Okazaki K, Jourdan-LeSaux C, Csiszar K, Bryant-Greenwood GD: Lysyl oxidases: expression in the fetal membranes and placenta. Placenta. 2001, 22: 49-57. 10.1053/plac.2000.0580.CrossRefPubMed Hein S, Yamamoto SY, Okazaki K, Jourdan-LeSaux C, Csiszar K, Bryant-Greenwood GD: Lysyl oxidases: expression in the fetal membranes and placenta. Placenta. 2001, 22: 49-57. 10.1053/plac.2000.0580.CrossRefPubMed
38.
go back to reference Saalbach A, Aneregg U, Bruns M, Schnabel E, Herrmann K, Haustein UF: Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol. 1996, 106: 1314-1319. 10.1111/1523-1747.ep12349035.CrossRefPubMed Saalbach A, Aneregg U, Bruns M, Schnabel E, Herrmann K, Haustein UF: Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol. 1996, 106: 1314-1319. 10.1111/1523-1747.ep12349035.CrossRefPubMed
39.
go back to reference Richardson RL, Hausman GJ, Campion DR: Response of pericytes to thermal lesion in the inguinal fat pad of 10-day-old rats. Acta Anat (Basel). 1982, 114: 41-57.CrossRef Richardson RL, Hausman GJ, Campion DR: Response of pericytes to thermal lesion in the inguinal fat pad of 10-day-old rats. Acta Anat (Basel). 1982, 114: 41-57.CrossRef
40.
go back to reference Cooper SM, Keyser AJ, Beaulieu AD, Ruoslahti E, Nimni ME, Quismorio FP: Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum. 1979, 22: 983-987.CrossRefPubMed Cooper SM, Keyser AJ, Beaulieu AD, Ruoslahti E, Nimni ME, Quismorio FP: Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum. 1979, 22: 983-987.CrossRefPubMed
41.
go back to reference Sorrell JM, Baber BA, Caplan AI: Construction of a bilayered dermal equivalent containing human papillary and reticular dermal fibroblasts: use of fluorescent vital dyes. Tissue Engineering. 1996, 2: 39-49.CrossRefPubMed Sorrell JM, Baber BA, Caplan AI: Construction of a bilayered dermal equivalent containing human papillary and reticular dermal fibroblasts: use of fluorescent vital dyes. Tissue Engineering. 1996, 2: 39-49.CrossRefPubMed
42.
go back to reference Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004, 113: 243-252. 10.1172/JCI200418847.PubMedCentralCrossRefPubMed Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004, 113: 243-252. 10.1172/JCI200418847.PubMedCentralCrossRefPubMed
43.
go back to reference Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG, Blackwell TS: Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med. 2005, 171: 899-907. 10.1164/rccm.200311-1535OC.CrossRefPubMed Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG, Blackwell TS: Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med. 2005, 171: 899-907. 10.1164/rccm.200311-1535OC.CrossRefPubMed
44.
go back to reference Helmbold P, Fiedler E, Fischer M, Marsch WC: Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol. 2004, 31: 431-440. 10.1111/j.0303-6987.2004.00203.x.CrossRefPubMed Helmbold P, Fiedler E, Fischer M, Marsch WC: Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol. 2004, 31: 431-440. 10.1111/j.0303-6987.2004.00203.x.CrossRefPubMed
45.
go back to reference Szulgit G, Rudolph R, Wandel A, Tenenhaus M, Panos R, Gardner H: Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. J Invest Dermatol. 2002, 118: 409-415. 10.1046/j.0022-202x.2001.01680.x.CrossRefPubMed Szulgit G, Rudolph R, Wandel A, Tenenhaus M, Panos R, Gardner H: Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. J Invest Dermatol. 2002, 118: 409-415. 10.1046/j.0022-202x.2001.01680.x.CrossRefPubMed
46.
go back to reference Furuhashi M, Sjoblom T, Abramsson A, Ellingsen J, Micke P, Li H, Bergsten-Folestad E, Eriksson U, Heuchel R, Betsholtz C, et al: Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res. 2004, 64: 2725-2733.CrossRefPubMed Furuhashi M, Sjoblom T, Abramsson A, Ellingsen J, Micke P, Li H, Bergsten-Folestad E, Eriksson U, Heuchel R, Betsholtz C, et al: Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res. 2004, 64: 2725-2733.CrossRefPubMed
Metadata
Title
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis
Authors
Vineeth S Rajkumar
Kevin Howell
Katalin Csiszar
Christopher P Denton
Carol M Black
David J Abraham
Publication date
01-09-2005
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2005
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1790

Other articles of this Issue 5/2005

Arthritis Research & Therapy 5/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.